Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

34

Revenue 2017

Tivicay

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tivicay was produced by AbbVie and Eisai.

GSK’s says depot HIV injection works over three years

GSK’s says depot HIV injection works over three years

Earlier this year,   GSK won approval for oral two-drug regimen Juluca – based on integrase inhibitor Tivicay (dolutegravir) and rilpivirine – that aims to provide effective control of HIV with a single

ViiV chalks up another win for two-drug HIV regimen

ViiV chalks up another win for two-drug HIV regimen few years due to the success of drugs like oral integrase inhibitor Tivicay (dolutegravir) and triple regimen Triumeq (dolutegravir/lamivudine/abacavir). ... effects. Last month for example, ViiV showed that an oral formulation of Tivicay with nucleoside

GSK two-drug trial in untreated HIV raises Gilead rivalry

GSK two-drug trial in untreated HIV raises Gilead rivalry The combination of integrase inhibitor Tivicay (dolutegravir) with nucleoside reverse transcriptase inhibitor Epivir (lamivudine) had similar efficacy to treatment with dolutegravir plus tenofovir disoproxil fumarate and emtricitabine – two

Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval

Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval It combines ViiV’s own Tivicay (dolutegravir) the most widely prescribed integrase inhibitor worldwide, and J&J’s  Edurant (rilpivirine).

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more the US, analysts say the drug combination is already gaining market share from GSK’s Triumeq and Tivicay.

1 2 3 4 5 6 7 8 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics